REQUEST A DEMO
Total
USD $0.00
Search more companies

Poltreg S.A. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Poltreg S.A. Profile Updated: October 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

PolTREG S.A. is a biotechnology company founded in 2015. The company is headquartered in Gdansk and has a Research and Development Center located there as well. The company's mission is to develop effective therapies for autoimmune diseases based on T-regulatory cells (TREG). PolTREG has four advanced projects in clinical trials focused on type 1 diabetes and multiple sclerosis. Additionally, the company has projects involving next-generation genetically modified T-regulatory lymphocytes in its portfolio.

Headquarters
ul. Botaniczna 20
Gdansk; Pomorskie; Postal Code: 80-298

Contact Details: Purchase the Poltreg S.A. report to view the information.

Website: http://www.poltreg.com

Basic Information
Total Employees:
Purchase the Poltreg S.A. report to view the information.
Outstanding Shares:
Purchase the Poltreg S.A. report to view the information.
Registered Capital:
Purchase the Poltreg S.A. report to view the information.
Financial Auditors:
Purchase the Poltreg S.A. report to view the information.
Incorporation Date:
September 15, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
21.31%
Purchase this report to view the information.
18.97%
Purchase this report to view the information.
7.78%
Purchase this report to view the information.
7.63%
Purchase this report to view the information.
5.24%
Company Performance
Financial values in the chart are available after Poltreg S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-88.88%
Total operating revenue
-73.99%
Operating profit (EBIT)
-40.21%
EBITDA
-33.12%
Net Profit (Loss) for the Period
-87.4%
Total assets
-8.28%
Total equity
-35.19%
Operating Profit Margin (ROS)
-8407.53%
Net Profit Margin
-7805.45%
Return on Equity (ROE)
-6.84%
Debt to Equity Ratio
3.6%
Quick Ratio
-4.8%
Cash Ratio
-3.81%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?